Associate FUEL Rotational Program - Amgen
Apr 23, 2024Valery Hernández-Rodríguez is an Associate FUEL Rotational Program at Amgen
Advisor Toxicologist (MIH Leadership Development Program) - ELI Lilly & Company
Apr 16, 2024Chiamaka (Chi-Chi) Ukachukwu, Ph.D is an ‘Advisor’ and she is a full-time employee in the Medicines Innovation Hub (MIH) Leadership Development Program (LDP).
Director, Alliances - Arrowhead Pharmaceuticals
Apr 09, 2024Tamisha Vaughan, PhD, manages programs Arrowhead has partnered with or licensed ranging from Discovery to Ph3 stages.
Advisor in Investigative Toxicology at Eli Lilly
Apr 02, 2024Ariana D. Cherry PhD, is a part of Talent Development Academy (TDA) Leadership Development Rotational Program (LDP). She was hired on as a full-time employee with the opportunity to complete three, 8-
Principal Scientist in late-stage Drug Substance Process Development at Amgen
Mar 28, 2024Angel Santiago-Lopez, PhD is a Principal Scientist in late-stage Drug Substance Process Development at Amgen. He leads a team of cell culture and protein purification scientists.
Preclinical Senior Scientist in Oral Formulations at Merck
Mar 26, 2024Mario Guitierrez, PhD, is a Preclinical Senior Scientist in Oral Formulations at Merck. As a formulation scientist, he works to optimize drug product formulations for clinical supply.
Preclinical Toxicologist at Johnson & Johnson Innovative Medicine
Mar 19, 2024Kelsey Johnson, PhD, is a Preclinical Toxicologist. She coordinates toxicology studies focused on assessing potential adverse effects of novel pharmaceutical compounds.
Sr. Scientist of Regulatory Affairs International at Merck & Co.
Mar 12, 2024LaKeisha Batts PhD, provides regulatory oversight for the development and approval of clinical trial applications (Phases I-V) in ex-US countries and have global responsibility for all regulatory acti
System Verification Engineer at Johnson & Johnson
Mar 05, 2024System Verification Engineer: create, validate, and execute test methods to verify capital system requirements.
Senior Scientist at AstraZeneca
Feb 27, 2024I work as a senior scientist for AstraZeneca were I am part of a team that evaluates oncology drug
targets and novel therapies.
Associate Director, DPDS Programs & Business Operations at J & J Innovative Med
Feb 20, 2024She leads early career development programs and strategic operations for their discovery organization to ensure that their business is running efficiently
Physician-Scientist at Johnson & Johnson
Feb 14, 2024I practice evidence-based medicine by integrating pharmacology, exposure, epidemiology, and clinical data to drive drug development decisions with a patient-centric focus.
Associate Director in Upstream Development, J&J Innovative Medicines
Dec 13, 2023Dr. Nancy Guillen was recently appointed as an Associate Director in Upstream Development at (J&J) Innovative Medicines
Medical Sciences Liaison (MSL), Merck
Dec 11, 2023Dr. Alia Toro is a Medical Sciences Liaison (MSL) who provides support to the Oncology Department at Merck, Puerto Rico.
Senior New Product Development Engineer, Edwards Lifesciences
Dec 11, 2023David Swain works in works in the Advanced Technology Business unit at Edwards Lifesciences
Investigator in R&D drug discovery, GSK
Dec 05, 2023Dr. Ivelisse Cruz-Torres works in matrix teams with the goal of evaluating potential targets to treat neurodegenerative diseases.